We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Discussing the pharma potshots after Tuesday night's Democratic debate, Maris said that "this follows our thesis that overall, things are getting tougher, not easier for the industry as both Trump and Biden want to make pricing tougher."